Study to Assess the Efficacy and Safety of Sitagliptin Added to the Regimen of Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin (0431-189)
Clinical trial NCT00875394 · COMPLETED
Trial details
- NCT number
- NCT00875394
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-02-01
- Primary completion
- 2008-06-27
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.